We are live on ! Find out more
DA

DCM Advisors Portfolio holdings

AUM $220M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+11.91%
1 Year Est. Return
+23.37%
3 Year Est. Return
+90.43%
5 Year Est. Return
+134.09%
10 Year Est. Return
AUM
$339M
AUM Growth
+$79.3M
Cap. Flow
+$54.1M
Cap. Flow %
15.97%
Top 10 Hldgs %
35.01%
Holding
336
New
54
Increased
92
Reduced
59
Closed
116

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$1.57M
2
QRVO icon
Qorvo
QRVO
+$1.5M
3
SBUX icon
Starbucks
SBUX
+$1.5M
4
IPG
Interpublic Group of Companies
IPG
+$1.44M
5
VEEV icon
Veeva Systems
VEEV
+$1.32M

Sector Composition

Rank Sector Weight
1 Technology 25.86%
2 Financials 19.81%
3 Communication Services 14.11%
4 Healthcare 10.24%
5 Consumer Discretionary 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORC
201
Orchid Island Capital
ORC
$1.3B
$124K 0.04%
5,493
-12,699
-70% -$304K
EEM icon
202
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$123K 0.04%
2,515
-3,135
-55% -$158K
ARKK icon
203
ARK Innovation ETF
ARKK
$5.66B
$119K 0.04%
1,257
-1,855
-60% -$203K
GLDI icon
204
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$31.1M
$111K 0.03%
655
-2,755
-81% -$465K
X
205
DELISTED
US Steel
X
$109K 0.03%
4,570
-17,130
-79% -$404K
XFLT
206
XAI Floating Rate & Alternative Income Trust
XFLT
$286M
$90K 0.03%
2,010
-1,740
-46% -$78K
PAYS icon
207
Paysign
PAYS
$501M
$66K 0.02%
41,500
ARKG icon
208
ARK Genomic Revolution ETF
ARKG
$1.55B
$41K 0.01%
672
-1,475
-69% -$102K
IBB icon
209
iShares Biotechnology ETF
IBB
$9.34B
$38K 0.01%
+250
New +$38.7K
VCR icon
210
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$26K 0.01%
75
-75
-50% -$25.2K
IWN icon
211
iShares Russell 2000 Value ETF
IWN
$14.3B
$25K 0.01%
150
ARKQ icon
212
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.89B
$21K 0.01%
275
-1,700
-86% -$139K
TIP icon
213
iShares TIPS Bond ETF
TIP
$14.5B
$19K 0.01%
150
-700
-82% -$90.3K
ARKF icon
214
ARK Blockchain & Fintech Innovation ETF
ARKF
$710M
$18K 0.01%
450
-2,300
-84% -$111K
PFFL icon
215
ETRACS Monthly Pay 2x Leveraged Preferred Stock ETN
PFFL
$7.47M
$10K ﹤0.01%
530
-5,500
-91% -$103K
VZ icon
216
Verizon
VZ
$195B
$10K ﹤0.01%
200
-7,321
-97% -$382K
ARKW icon
217
ARK Web x.0 ETF
ARKW
$1.63B
$6K ﹤0.01%
50
-825
-94% -$117K
PRNT icon
218
The 3D Printing ETF
PRNT
$59.5M
$6K ﹤0.01%
165
BIOL
219
DELISTED
Biolase, Inc.
BIOL
$6K ﹤0.01%
7
-32
-82% -$40.4K
ARKX icon
220
ARK Space & Defense Innovation ETF
ARKX
$793M
$2K ﹤0.01%
100
ADSK icon
221
Autodesk
ADSK
$49.5B
-700
Closed -$200K
AREC icon
222
American Resources Corp
AREC
$191M
-10,900
Closed -$21K
AZN icon
223
AstraZeneca
AZN
$263B
-2,350
Closed -$282K
BFK
224
DELISTED
BlackRock Municipal Income Trust
BFK
-26,370
Closed -$390K
BMY icon
225
Bristol-Myers Squibb
BMY
$133B
-6,798
Closed -$402K

Similar funds

DCM Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, DCM Advisors held 336 positions worth $339M, up 31% from $260M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

DCM Advisors deployed $54.1M of net new capital in Q4 2021, opening 54 new positions and adding to 92 existing holdings. Its largest new stake was Union Pacific: 8,861 shares worth $2.23M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Starbucks, an estimated $1.5M trimmed.

  • DCM Advisors's largest Q4 2021 buy was Union Pacific: 8,861 shares worth $2.23M.
  • DCM Advisors added most to Apple in Q4 2021, an estimated $8.68M increase.
  • DCM Advisors's biggest Q4 2021 reduction was Starbucks, cutting an estimated $1.5M.
  • DCM Advisors fully exited MetLife in Q4 2021, selling an estimated $1.57M.
  • DCM Advisors's ten largest holdings make up 35% of its $339M portfolio in Q4 2021.
  • DCM Advisors opened 54 new positions and closed 116 in Q4 2021.
  • DCM Advisors's portfolio value rose 31% quarter-over-quarter to $339M.

Based on DCM Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.